What is Andes virus? Symptoms, how it spreads, and why it matters in South America

Andes virus (ANDV) is a member of the hantavirus group: RNA viruses that circulate silently in wild rodents and only occasionally spill into people. When they do, some hantaviruses cause hantavirus pulmonary syndrome (HPS), also called hantavirus cardiopulmonary syndrome (HCPS)—a febrile illness that can progress to respiratory failure. Andes virus is the dominant cause of HPS reported from parts of Chile and Argentina, and it is the strain public-health agencies most often discuss when they separate “South American hantavirus risk” from patterns seen elsewhere in the Americas.

Thinking clearly about Andes virus starts with the reservoir. Field studies and outbreak investigations have long tied ANDV to cricetid rodents, especially the long-tailed pygmy rice rat (Oligoryzomys longicaudatus) in Chilean settings, with other sigmodontine species implicated across overlapping geographies. The virus does not exist as a free-floating “forest plague”; it tracks rodent populations, habitat quality, and human activities that bring people into closed, dusty, rodent-infested spaces.

How people get infected

For essentially every hantavirus, the core risk is rodent-to-human exposure. People can inhale tiny particles carrying virus when dried urine, droppings, or nesting material are disturbed—think sweeping a rarely used cabin, cleaning a shed after winter, or working in grain storage without respiratory protection. Less commonly, bites or direct contact with mucous membranes after handling contaminated materials can matter. The practical lesson is mechanical: aerosols and hand-to-face contact after rodent contamination are the usual bridges, not casual conversation across a room.

What makes Andes virus distinctive on the world stage is person-to-person transmission. Most hantaviruses described in North America and Europe have not shown meaningful chains of household transmission. For ANDV, multiple investigations have documented spread associated with very close contact with a severely ill patient, particularly around the early symptomatic phase. Public-health guidance therefore treats close caregivers and intimate contacts differently than it treats the general public. Even so, this is not “airborne like measles”: risk concentrates in specific caregiving and domestic proximity contexts, not in ordinary community mixing.

Where and when cases cluster

Endemic risk is regional. Surveillance narratives consistently highlight southern Chile (including Los Lagos and neighbouring zones) and multiple Argentine provinces where rodent exposure is common. Case counts often rise in spring and summer in the Southern Hemisphere when rodent numbers and human outdoor activity can align—exact seasonal curves vary by locality, but the pattern is ecological rather than random.

Travelers are not the typical denominator for global case totals, but the geography matters for trip planning. Activities that mirror local high-risk exposures—camping in rodent-rich shelters, unsupervised cleanup of rural buildings, or occupational fieldwork without controls—are the logical questions for a pre-trip briefing, not subway rides through a capital city.

What illness looks like

Clinically, HPS often begins like many viral syndromes: fever, muscle aches, headache, fatigue, sometimes nausea or abdominal discomfort. After exposure, illness may appear after roughly 1 to 8 weeks, a long window that complicates recall of the exact risky activity. The course that alarms clinicians is progression over hours to days into shortness of breath, hypoxia, and pulmonary edema as capillary leak floods lung tissue. Blood pressure can fall as the cardiovascular system decompensates. Because early symptoms are nonspecific, the decisive clues are often exposure history (rodent habitat, known outbreak geography) plus rapid deterioration—reason enough to seek urgent evaluation if the combination fits.

Severity is not uniform, but HPS is never something to downplay. Published reviews and national summaries commonly cite aggregate case fatality from about 12% to about 40% for South American HPS, while any single outbreak or hospital series can land higher or lower depending on surveillance, treatment access, and how mild cases are counted. The point for readers is simpler: this is a high-consequence zoonosis, not a routine cold, and outcomes improve when intensive supportive care begins early.

Diagnosis and response

Diagnosis relies on specialized laboratory testing and compatible clinical findings; it is not a home test diagnosis. Public-health systems use serology and molecular methods in reference laboratories, sometimes alongside epidemiologic links during recognized clusters. Clinicians in endemic areas maintain higher suspicion during peak seasons; elsewhere, a recent rural exposure in Chile or Argentina can be the trigger for testing conversations.

There is no widely deployed vaccine for Andes virus for the general public comparable to routine immunization programmes, and no simple outpatient antiviral that replaces hospital-level supportive care. Management emphasises oxygen, hemodynamic support, and ICU-level monitoring when shock or respiratory failure develops. That reality places extra weight on prevention and early recognition.

Prevention that actually matches the biology

Prevention is mostly rodent-source control: seal holes, store food in rodent-resistant containers, reduce indoor nesting sites, and avoid attracting animals into sleeping quarters. When cleaning a suspect space, follow health-authority advice to wet disinfect rather than dry-sweep, wear gloves, improve ventilation before disturbing dust, and use appropriate respiratory protection for heavy cleanups. After known close contact with a confirmed case in an outbreak setting, public-health teams may recommend monitoring; follow local guidance rather than improvising.

How Andes virus differs from “the” hantavirus in North America

Media shorthand often says “hantavirus” as if it were one bug. In the United States, Sin Nombre virus and related strains dominate HPS narratives, with deer mice (Peromyscus) central to ecology. The viruses are cousins in virology, but geography, host species, and transmission nuance differ. Andes virus’s documented person-to-person component is the headline distinction for policy and household precautions; Sin Nombre–type patterns emphasise rodent exposure almost exclusively in most settings.

Bottom line

Andes virus is a zoonotic hantavirus maintained by wild rodents in parts of southern South America. Humans typically become infected by breathing contaminated dust or through close contact with rodent environments; severe disease manifests as hantavirus pulmonary syndrome, which can progress quickly and carries substantial mortality risk. Limited person-to-person spread separates ANDV from many other hantaviruses and justifies targeted public-health measures during outbreaks. For most readers, the actionable summary is: understand the reservoir, respect rural cleanup and housing risks, seek care promptly if a compatible severe illness follows exposure, and rely on national health agencies and clinicians rather than social-media cures.